Today: 9 April 2026
Deutsche Telekom Stock Today (Nov 13, 2025): Frankfurt edges higher after Q3; dividend lifted to €1 and €2bn buyback planned
13 November 2025
2 mins read

Deutsche Telekom Stock Today (Nov 13, 2025): Frankfurt edges higher after Q3; dividend lifted to €1 and €2bn buyback planned

FRANKFURT/NEW YORK — November 13, 2025. Deutsche Telekom shares were a touch higher in Frankfurt after the group nudged up its full‑year outlook again alongside third‑quarter results and proposed a bigger dividend. In the U.S., the ADRs will have their say when Wall Street opens later today. Reuters+1

Live price snapshot (Germany & U.S.)

  • Frankfurt (Xetra: DTE) — By mid‑morning, the stock changed hands around €27.39, up roughly 0.3%; it opened at €27.36. For context, the 52‑week range on the German line is €26.00–€35.91. Figures are delayed and intraday. MarketScreener+2DIE WELT+2
  • U.S. ADR (OTC: DTEGY) — The ADR closed Wednesday at $31.70; the 52‑week range sits near $29.29–$39.04 ahead of today’s U.S. session. MarketWatch+1

What’s moving the stock today

Deutsche Telekom’s Q3 numbers landed broadly in line with expectations, but the company raised 2025 guidance and signaled higher shareholder returns. Management now sees adjusted EBITDA AL around €45.3bn (vs. prior “>€45bn”) and free cash flow after leases around €20.1bn (vs. prior “>€20bn”). The board also targets a dividend increase to €1.00 per share for the 2025 financial year. Reuters+1

A key driver of the outlook tweak is the consolidation of UScellular, folded into T‑Mobile’s U.S. operations from early August after a $4.4bn deal; T‑Mobile had flagged a $400m Q3 service‑revenue lift from that transaction. Reuters

Q3 2025 at a glance

  • Revenue: €28.9bn, up 3.3% organically; service revenue up 3.6% organically. Telekom
  • Core profit:Adjusted EBITDA AL €11.1bn (organic +2.9%). Telekom
  • Free cash flow AL:€5.6bn in Q3 (‑9.2% YoY); €16.1bn for the first nine months (+6.8% YoY). Telekom
  • Earnings:Adjusted net profit €2.7bn (+14.3% YoY). Reported net profit €2.43bn (‑17.9% YoY) reflecting fewer positive special items than a year ago. Telekom+1

Shareholder returns: dividend and buyback

Alongside the €1 dividend proposal for the 2025 financial year, Deutsche Telekom plans a share buyback of up to €2bn in 2026, subject to approvals. It’s the most explicit signal yet that cash generation remains robust even after heavy network investment. Telekom

Operating highlights worth noting

  • Germany (fixed & mobile): Fiber‑to‑the‑home momentum accelerated, with 155,000 net FTTH additions in Q3—its best quarter for pure fiber users—taking FTTH passings to 11.8 million households. Mobile service revenue grew 1.8% organically. Telekom
  • United States: T‑Mobile delivered industry‑leading postpaid growth with 2.3 million net adds (including 1.0 million postpaid phone), and raised full‑year postpaid guidance. Telekom
  • Europe (ex‑U.S., ex‑Germany):Adjusted EBITDA AL +4.6% organically; management continues to target 4–5% medium‑term growth for the region. Telekom
  • T‑Systems (IT services):Adjusted EBITDA AL +22.8% organically on improved cloud profitability. Telekom

Context for 2025 and beyond

Today’s guidance bump follows incremental raises earlier this year and dovetails with Deutsche Telekom’s push in AI and cloud—highlighted this month by plans with Nvidia for an EU‑based AI cloud initiative—as well as ongoing network build‑outs. While the AI effort is longer‑dated, investors are treating the UScellular integration and cash‑return roadmap as the nearer‑term catalysts. Reuters

What to watch next

  • U.S. trading reaction: With ADRs last closing at $31.70, watch the open and early volumes as American investors price in the higher dividend and buyback plan. MarketWatch
  • Execution on U.S. integration: The scale and timing of synergies from UScellular’s consolidation will be a recurring theme on calls and in quarterly updates. Reuters
  • Fiber build‑out economics: Management intends to leverage tax incentives to accelerate German fiber investment; uptake rates will shape mid‑term returns. Telekom
  • Next dates: The company’s full‑year 2025 results are scheduled for February 26, 2026; that’s the next checkpoint for capital‑return details and guidance fine‑tuning. Telekom

Methodology & timestamps: Frankfurt prices and opening print reflect Xetra data and German financial outlets as of Thursday morning, Nov 13, 2025; U.S. ADR figures reference the Nov 12 close ahead of today’s session. Always check your broker for real‑time quotes. MarketScreener+2DIE WELT+2

Sources: Deutsche Telekom Q3 2025 media release and investor materials; Reuters coverage; MarketScreener, MarketWatch, and other market data providers cited throughout. MarketWatch+3Telekom+3Reuters+3

CEO of TS2 Space and founder of TS2.tech. Expert in satellites, telecommunications, and emerging technologies, covering trends in space, AI, and connectivity.

Stock Market Today

  • Ultragenyx Pharmaceutical Shares Surge 8.1% Weekly Amid Valuation Debate
    April 9, 2026, 2:08 AM EDT. Ultragenyx Pharmaceutical (RARE) shares rose 8.1% last week to $23.15 amid mixed performance, down 1.9% year-to-date and 31.7% over 12 months. The biotech specializes in rare disease treatments, a sector sensitive to clinical trial and regulatory updates. Despite recent gains, the company's long-term returns remain negative. A discounted cash flow (DCF) analysis values Ultragenyx at about $257.43 per share, suggesting it is 91% undervalued based on future free cash flow projections turning positive by 2026. However, actual cash flow remains negative at $501.5 million last year. Investors must weigh DCF optimism against market risks and sector volatility. Ultragenyx scores 4 out of 6 in valuation, indicating some appeal but highlighting areas needing scrutiny.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 09.04.2026

9 April 2026
LIVEMarkets rolling coverageStarted: April 9, 2026, 12:00 AM EDTUpdated: April 9, 2026, 2:13 AM EDT Ultragenyx Pharmaceutical Shares Surge 8.1% Weekly Amid Valuation Debate April 9, 2026, 2:08 AM EDT. Ultragenyx Pharmaceutical (RARE) shares rose 8.1% last week to $23.15 amid mixed performance, down 1.9% year-to-date and 31.7% over 12 months. The biotech specializes in rare disease treatments, a sector sensitive to clinical trial and regulatory updates. Despite recent gains, the company's long-term returns remain negative. A discounted cash flow (DCF) analysis values Ultragenyx at about $257.43 per share, suggesting it is 91% undervalued based on future free cash flow
Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

8 April 2026
IREN shares rose 1.8% to $35.74 Wednesday as investors assessed its $6 billion share program and shift from bitcoin mining to AI cloud services. The company’s revenue fell to $184.7 million last quarter, with a net loss of $155.4 million. IREN recently announced a five-year, $9.7 billion AI cloud deal with Microsoft. Options trading volume hit 103,000 contracts Tuesday, with sentiment described as mixed.
Amazon Stock Could Jump 50% as Wall Street Reconsiders Its $200 Billion AI Bet

Amazon Stock Could Jump 50% as Wall Street Reconsiders Its $200 Billion AI Bet

8 April 2026
Amazon closed at $213.77 Tuesday, with BNP Paribas maintaining a $320 price target, citing strong AI demand despite Amazon’s planned $200 billion capex for 2026. The company’s February forecast of higher spending sent shares down 11.5% after hours, even as AWS revenue rose 24% to $35.6 billion in the December quarter. Alphabet and Microsoft are also ramping up AI infrastructure spending.
Sensex Soars 2,946 Points, Nifty Near 24,000 After Iran Ceasefire and RBI Pause

Sensex Soars 2,946 Points, Nifty Near 24,000 After Iran Ceasefire and RBI Pause

8 April 2026
The Sensex surged 2,946 points to 77,562.90 on Wednesday, its best day in five years, as a U.S.-Iran ceasefire and steady RBI rates pushed Indian markets higher. Brent crude fell 14.4% to $93.49 a barrel, easing pressure on the rupee, which rose 0.5% to 92.58 per dollar. All 16 major sectors gained, led by financials and auto stocks. The RBI kept its repo rate at 5.25% and forecast slower growth ahead.
Netflix Stock Draws Fresh Institutional Buying Ahead of Earnings After Goldman Upgrade

Netflix Stock Draws Fresh Institutional Buying Ahead of Earnings After Goldman Upgrade

8 April 2026
Stock Yards Bank & Trust Co. increased its Netflix stake by 1,141.9% to 29,074 shares in Q4, while Ethos Capital Management disclosed a new 19,610-share position worth $1.84 million. The moves come ahead of Netflix’s April 16 earnings report and follow a Goldman Sachs upgrade to Buy with a $120 target. Insiders Reed Hastings and Greg Peters sold shares earlier this year under preset trading plans. Netflix last traded at $98.82.
Valve Revives Steam Machine: Specs, 4K‑60 Ambitions, New Steam Controller & VR Headset — Everything Announced (Nov 13, 2025)
Previous Story

Valve Revives Steam Machine: Specs, 4K‑60 Ambitions, New Steam Controller & VR Headset — Everything Announced (Nov 13, 2025)

Rolls-Royce Soars to Record High: What’s Fueling the Unstoppable Rally?
Next Story

Rolls‑Royce Share Price Today (13 Nov 2025): RR.L edges lower after in‑line trading update as guidance held and flying hours rise

Go toTop